U.S. Judge Lourdes G. Baird of the Central District of California has entered a permanent injunction ordering Pfizer Inc. to cease using the mark Trovan to identify an antibiotic (Trovan Ltd., et al. v. Pfizer Inc., No. CV-98-0094 LGB, C.D. Calif.).
The judge’s Feb. 24 order also finalized an Oct. 12 jury award of $143 million for Trovan Ltd., a British company which owns the registered trademark Trovan, and its American licensee, Electronic Identification Devices Ltd. She denied the plaintiffs’ motion for treble damages or profits, finding the $143 million jury award ample compensation. The award, believed to be the largest trademark infringement verdict ever entered, consists of $5 million in general damages, $3 million in royalties and $135 million in punitive damages.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Not a Bloomberg Law Subscriber?
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]